Close Menu

NEW YORK (GenomeWeb) – Link Technologies today announced it has signed two new Japanese distributors, Tokyo-based Cosmo Bio and Osaka-based Shigematsu.

The firms will work alongside Gene Design to provide Bellshill, Scotland-based Link's reagents for oligonucleotide synthesis and modification.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.